Natural polyphenol disposition via coupled metabolic pathways
- PMID: 17539746
- PMCID: PMC2777985
- DOI: 10.1517/17425255.3.3.389
Natural polyphenol disposition via coupled metabolic pathways
Abstract
A major challenge associated with the development of chemopreventive polyphenols is the lack of bioavailability in vivo, which are primarily the result of coupled metabolic activities of conjugating enzymes and efflux transporters. These coupling processes are present in disposition tissues and organs in mammals and are efficient for the purposes of drug metabolism, elimination and detoxification. Therefore, it was expected that these coupling processes represent a significant barrier to the oral bioavailabilities of polyphenols. In various studies of this coupling process, it was identified that various conjugating enzymes such as uridine 5'-diphosphate-glucuronosyltransferase and sulfotransferase are capable of producing very hydrophilic metabolites of polyphenols, which cannot diffuse out of the cells and needs the action of efflux transporters to pump them out of the cells. Additional studies have shown that efflux transporters, such as multi-drug resistance-associated protein 2, breast cancer-resistant protein and the organic anion transporters, appear to serve as the gate keeper when there is an excess capacity to metabolise the compounds. These efflux transporters may also act as the facilitator of metabolism when there is a product/metabolite inhibition. For polyphenols, these coupled processes enable a duo recycling scheme of enteric and enterohepatic recycling, which allows the polyphenols to be reabsorbed and results in longer than expected apparent plasma half-lifes for these compounds and their conjugates. Because the vast majority of polyphenols in plasma are hydrophilic conjugates, more research is needed to determine if the metabolites are active or reactive, which will help explain their mechanism of actions.
Figures








Similar articles
-
Coupling of conjugating enzymes and efflux transporters: impact on bioavailability and drug interactions.Curr Drug Metab. 2005 Oct;6(5):455-68. doi: 10.2174/138920005774330657. Curr Drug Metab. 2005. PMID: 16248837 Review.
-
An update on polyphenol disposition via coupled metabolic pathways.Expert Opin Drug Metab Toxicol. 2019 Feb;15(2):151-165. doi: 10.1080/17425255.2019.1559815. Epub 2018 Dec 24. Expert Opin Drug Metab Toxicol. 2019. PMID: 30583703 Review.
-
Polyphenols: food sources and bioavailability.Am J Clin Nutr. 2004 May;79(5):727-47. doi: 10.1093/ajcn/79.5.727. Am J Clin Nutr. 2004. PMID: 15113710 Review.
-
How should we assess the effects of exposure to dietary polyphenols in vitro?Am J Clin Nutr. 2004 Jul;80(1):15-21. doi: 10.1093/ajcn/80.1.15. Am J Clin Nutr. 2004. PMID: 15213022 Review.
-
Bioavailability and metabolism of selected cocoa bioactive compounds: A comprehensive review.Crit Rev Food Sci Nutr. 2020;60(12):1947-1985. doi: 10.1080/10408398.2019.1619160. Epub 2019 May 24. Crit Rev Food Sci Nutr. 2020. PMID: 31124371 Review.
Cited by
-
Changes in Faecal Microbiota Profile and Plasma Biomarkers following the Administration of an Antioxidant Oleuropein-Rich Leaf Extract in a Rat Model Mimicking Colorectal Cancer.Antioxidants (Basel). 2024 Jun 14;13(6):724. doi: 10.3390/antiox13060724. Antioxidants (Basel). 2024. PMID: 38929163 Free PMC article.
-
UDP-glucuronosyltransferase (UGT) 1A9-overexpressing HeLa cells is an appropriate tool to delineate the kinetic interplay between breast cancer resistance protein (BRCP) and UGT and to rapidly identify the glucuronide substrates of BCRP.Drug Metab Dispos. 2012 Feb;40(2):336-45. doi: 10.1124/dmd.111.041467. Epub 2011 Nov 9. Drug Metab Dispos. 2012. PMID: 22071170 Free PMC article.
-
Interactions between CYP3A4 and Dietary Polyphenols.Oxid Med Cell Longev. 2015;2015:854015. doi: 10.1155/2015/854015. Epub 2015 Jun 9. Oxid Med Cell Longev. 2015. PMID: 26180597 Free PMC article. Review.
-
Flaxseed Lignans as Important Dietary Polyphenols for Cancer Prevention and Treatment: Chemistry, Pharmacokinetics, and Molecular Targets.Pharmaceuticals (Basel). 2019 May 5;12(2):68. doi: 10.3390/ph12020068. Pharmaceuticals (Basel). 2019. PMID: 31060335 Free PMC article. Review.
-
Effects of human oral mucosal tissue, saliva, and oral microflora on intraoral metabolism and bioactivation of black raspberry anthocyanins.Cancer Prev Res (Phila). 2011 Aug;4(8):1209-21. doi: 10.1158/1940-6207.CAPR-11-0040. Epub 2011 May 10. Cancer Prev Res (Phila). 2011. PMID: 21558412 Free PMC article.
References
-
- MEYER UA. Overview of enzymes of drug metabolism. J. Pharmacokinet. Biopharm. 1996;24(5):449–459. - PubMed
-
- WANG H, LECLUYSE EL. Role of orphan nuclear receptors in the regulation of drug-metabolizing enzymes. Clin. Pharmacokinet. 2003;42(15):1331–13357. - PubMed
-
- BANOGLU E. Current status of the cytosolic sulfotransferases in the metabolic activation of promutagens and procarcinogens. Curr. Drug Metab. 2000;1(1):1–30. - PubMed
-
- INNOCENTI F, GRIMSLEY C, DAS S, et al. Haplotype structure of the UDP-glucuronosyltransferases 1A1 promoter in different ethnic groups. Pharmacogenetics. 2002;12:725–733. - PubMed
-
- MANDLEKAR S, HONG JL, KONG AN. Modulation of metabolic enzymes by dietary phytochemicals: a review of mechanisms underlying beneficial versus unfavorable effects. Curr. Drug Metab. 2006;7(6):661–75. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources